(BPRW) GBT Opens 2021 ACCEL Grant Program, Providing up to $500,000 in Support to the Sickle Cell Disease Community

(Black PR Wire) SOUTH SAN FRANCISCO, Calif., March 08, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it is accepting proposals for the third annual Access to Excellent Care for S

CLICK HERE TO READ FULL ARTICLE